Boston Scientific's 2026 Guidance Cut Puts Its Recovery to the TestZacks Investment Research • 08/06/26
Should Investors Buy Boston Scientific Stock Despite Near-Term Risks?Zacks Investment Research • 08/05/26
Boston Scientific beats second quarter expectations, raises full-year outlookProactive Investors • 07/29/26
Boston Scientific (BSX) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 07/29/26
Boston Scientific Q2 Earnings & Revenues Top Estimates, Stock ClimbsZacks Investment Research • 07/29/26
Boston Scientific (BSX) Surpasses Q2 Earnings and Revenue EstimatesZacks Investment Research • 07/29/26
Boston Scientific (BSX) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance MeasuresZacks Investment Research • 07/24/26
Boston Scientific's Q2 Earnings Coming Up: Buy, Hold or Sell the Stock?Zacks Investment Research • 07/21/26
Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to NoteZacks Investment Research • 07/14/26